Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.32 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | CES2 | O00748 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | LTA4H | P09960 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1031778 | 0.77 | TP53 (0.41) | TP53PSIP1TSHRLMNAALOX12 | |
| SCHEMBL25355509 | 0.77 | TP53 (0.48) | TP53PSIP1TSHRLMNAALOX12 | |
| SCHEMBL898908 | 0.77 | TP53 (0.48) | TP53PSIP1TSHRLMNAALOX12 | |
| Hydrochloric Acid SCHEMBL15529862 | 0.74 | TP53 (0.46) | TP53PSIP1TSHRLMNAALOX12 | |
| SCHEMBL442385 | 0.74 | SIGMAR1 (0.39) | TP53TSHRATMSIGMAR1CES2 | |
| SCHEMBL11764852 | 0.72 | TP53 (0.38) | TP53PSIP1TSHRLMNAALOX12 | |
| SCHEMBL9745630 | 0.72 | TP53 (0.38) | TP53PSIP1TSHRLMNAALOX12 | |
| SCHEMBL25437026 | 0.72 | TP53 (0.38) | TP53PSIP1TSHRLMNAALOX12 | |
| SCHEMBL9747183 | 0.72 | TP53 (0.38) | TP53PSIP1TSHRLMNAALOX12 | |
| SCHEMBL9746002 | 0.72 | TP53 (0.38) | TP53PSIP1TSHRLMNAALOX12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118185199-A | High-flame-retardance durable electric wire and cable and preparation process thereof | 江西金杯赣昌电缆有限公司 | 2024-06-14 | — | — | CN | claimed |
| CN-116655457-A | Method for preparing resorcinol | 万华化学集团股份有限公司 | 2023-08-29 | — | — | CN | claimed |
| US-3989882-A | Process for preparing an alternating copolymer of a conjugated vinyl compound and an olefinic unsaturated compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-02 | — | — | US | claimed |
| CN-118185199-A | High-flame-retardance durable electric wire and cable and preparation process thereof | 江西金杯赣昌电缆有限公司 | 2024-06-14 | — | — | CN | disclosed |
| CN-116655457-A | Method for preparing resorcinol | 万华化学集团股份有限公司 | 2023-08-29 | — | — | CN | disclosed |
| US-20150080581-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | RIMTEC CORPORATION (JP) | 2015-03-19 | — | — | US | disclosed |
| US-8927670-B2 | Multicoordinated metal complexes for use in metathesis reactions | RIMTEC CORPORATION (JP) | 2015-01-06 | — | — | US | disclosed |
| EP-2397475-B1 | 4, 4' disubstituted 4H-cyclopentadithiophene and new methods for synthesising the same | IMEC (BE) | 2014-11-12 | — | — | EP | disclosed |
| US-8765882-B2 | Polythiophene based active layer for solar cells | IMEC (BE) | 2014-07-01 | — | — | US | disclosed |
| US-8450604-B2 | Polymerisable compounds for making opto-electronic devices | IMEC (BE) | 2013-05-28 | — | — | US | disclosed |
| US-8329923-B2 | 4, 4′ disubstituted 4H-cyclopentadithiophene and new methods for synthesizing the same | IMEC (BE) | 2012-12-11 | — | — | US | disclosed |
| US-20080293905-A9 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | RIMTEC CORPORATION (JP) | 2008-11-27 | — | — | US | disclosed |
| WO-2007022945-A2 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | VIACATT N.V. (BE) | 2007-03-01 | — | — | WO | disclosed |
| EP-1757613-A1 | Multicoordinated metal complexes for use in metathesis reactions | Viacatt N.V. (BE) | 2007-02-28 | — | — | EP | disclosed |
| US-20070043188-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | TELENE S.A.S. (FR) | 2007-02-22 | — | — | US | disclosed |
| US-4380673-A | RANEY NICKEL AND COPPER, SILVER, GOLD, TIN, LEAD, ZINC, CADMIUM, INDIUM OR GERMANIUM | INSTITUT FRANCAIS DU PETROLE (FR) | 1983-04-19 | — | — | US | disclosed |
| EP-0044835-A1 | CATALYSED ALTERNATING COPOLYMERISATION AND PRODUCT | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1982-02-03 | — | — | EP | disclosed |
| WO-1981001289-A1 | CATALYSED ALTERNATING COPOLYMERISATION AND PRODUCT | BAMFORD C | 1981-05-14 | — | — | WO | disclosed |
| US-4121032-A | Process for preparing alternating copolymer of conjugated vinyl compound and olefinic unsaturated compound with oxygen and boron compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1978-10-17 | — | — | US | disclosed |
| US-3989882-A | Process for preparing an alternating copolymer of a conjugated vinyl compound and an olefinic unsaturated compound | SUMITOMO CHEMICAL COMPANY, LIMITED (JA) | 1976-11-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150080581-A1 | MULTICOORDINATED METAL COMPLEXES FOR USE IN METATHESIS REACTIONS | APEX1, SOD1, AP1M1 | TP53 3310/4885PSIP1 2881/4885TSHR 4417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.